Xvivo Perfusion AB (XVIPF)
30.95
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Xvivo Perfusion Max Drawdown (5Y) : 78.31% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 78.31% |
| June 30, 2026 | 78.31% |
| May 31, 2026 | 78.31% |
| April 30, 2026 | 78.31% |
| March 31, 2026 | 78.31% |
| February 28, 2026 | 78.31% |
| January 31, 2026 | 78.31% |
| December 31, 2025 | 78.31% |
| November 30, 2025 | 78.31% |
| October 31, 2025 | 78.31% |
| September 30, 2025 | 78.31% |
| August 31, 2025 | 78.31% |
| July 31, 2025 | 78.31% |
| June 30, 2025 | 78.31% |
| May 31, 2025 | 78.31% |
| April 30, 2025 | 78.31% |
| March 31, 2025 | 78.31% |
| February 28, 2025 | 78.31% |
| January 31, 2025 | 78.31% |
| December 31, 2024 | 78.31% |
| November 30, 2024 | 78.31% |
| October 31, 2024 | 78.31% |
| September 30, 2024 | 78.31% |
| August 31, 2024 | 78.31% |
| July 31, 2024 | 78.31% |
| Date | Value |
|---|---|
| June 30, 2024 | 78.31% |
| May 31, 2024 | 78.31% |
| April 30, 2024 | 78.31% |
| March 31, 2024 | 78.31% |
| February 29, 2024 | 78.31% |
| January 31, 2024 | 78.31% |
| December 31, 2023 | 78.31% |
| November 30, 2023 | 78.31% |
| October 31, 2023 | 78.31% |
| September 30, 2023 | 78.31% |
| August 31, 2023 | 78.31% |
| July 31, 2023 | 78.31% |
| June 30, 2023 | 78.31% |
| May 31, 2023 | 78.31% |
| April 30, 2023 | 78.31% |
| March 31, 2023 | 78.31% |
| February 28, 2023 | 78.31% |
| January 31, 2023 | 78.31% |
| December 31, 2022 | 78.31% |
| November 30, 2022 | 78.31% |
| October 31, 2022 | 78.31% |
| September 30, 2022 | 60.60% |
| August 31, 2022 | 60.60% |
| July 31, 2022 | 60.16% |
| June 30, 2022 | 60.16% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Getinge AB | 67.92% |
| Paxman AB | 61.64% |
| Enovis Corp. | 77.93% |
| Edwards Lifesciences Corp. | 54.32% |
| Intuitive Surgical, Inc. | 49.90% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -18.62 |
| Beta (5Y) | 0.3647 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 58.66% |
| Historical Sharpe Ratio (5Y) | -0.2602 |
| Historical Sortino (5Y) | -0.474 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 23.59% |